Mead Johnson Enfamil Ads Withdrawn After Restraining Order
This article was originally published in The Tan Sheet
Executive Summary
Mead Johnson distributed roughly 90,000 letters in late April informing pediatricians its previously circulated literature regarding store-brand infant formulas contained incorrect information about calcium and folic acid levels.
You may also be interested in...
Class Action Claims Often Follow Regulatory Action, Industry Litigation
FDA warning letters, FTC consent orders, Lanham Act litigation and National Advertising Division reviews all provide fodder for attorneys looking to bring consumer product lawsuits. While some case settlements come with large monetary payments, injunctive components also are common and often costly.
Class Action Claims Often Follow Regulatory Action, Industry Litigation
FDA warning letters, FTC consent orders, Lanham Act litigation and National Advertising Division reviews all provide fodder for attorneys looking to bring consumer product lawsuits. While some case settlements come with large monetary payments, injunctive components also are common and often costly.
Class Action Claims Often Follow Regulatory Action, Industry Litigation
FDA warning letters, FTC consent orders, Lanham Act litigation and National Advertising Division reviews all provide fodder for attorneys looking to bring consumer product lawsuits. While some case settlements come with large monetary payments, injunctive components also are common and often costly.